WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004030637) TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/030637    International Application No.:    PCT/US2003/009717
Publication Date: 15.04.2004 International Filing Date: 31.03.2003
Chapter 2 Demand Filed:    08.03.2004    
IPC:
A61K 31/41 (2006.01), A61K 31/437 (2006.01), A61K 31/4439 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US) (For All Designated States Except US).
BRADBURY, Margaret, J. [US/US]; (US) (For US Only).
COSFORD, Nicholas, D. P. [GB/US]; (US) (For US Only).
VARNEY, Mark, A. [US/US]; (US) (For US Only).
ANDERSON, Jeffery, J. [US/US]; (US) (For US Only)
Inventors: BRADBURY, Margaret, J.; (US).
COSFORD, Nicholas, D. P.; (US).
VARNEY, Mark, A.; (US).
ANDERSON, Jeffery, J.; (US)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US)
Priority Data:
PCT/US02/31294 01.10.2002 US
PCT/US02/41720 13.12.2002 US
PCT/US02/40147 13.12.2002 US
PCT/US02/40237 16.12.2002 US
PCT/US02/40486 17.12.2002 US
Title (EN) TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE
(FR) TRAITEMENT DE L'OBESITE ET D'AUTRES TROUBLES ASSOCIES A UNE CONSOMMATION ALIMENTAIRE EXCESSIVE
Abstract: front page image
(EN)Modulators of metabotropic glutamate receptor-5 (mGluR5) are useful in treating disorders associated with excessive food intake, including obesity and obesity-related disorders. In particular, mGluR5 antagonists of structural formulae IA-IF are useful in treating these conditions, either as single agents or in combination with other compounds useful for treating obesity.
(FR)La présente invention concerne des modulateurs des récepteurs 5 métabotropiques du glutamate (mGluR5) utiles pour traiter des troubles associés à une consommation alimentaire excessive, y compris l'obésité et les troubles associés à l'obésité. Plus particulièrement, l'invention concerne les antagonistes des mGluR5 représentés par les formules IA-IF, lesquels sont utiles pour traiter de telles affections soit en tant qu'agents uniques, soit en combinaison avec d'autres composés utilisés pour le traitement de l'obésité.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)